Brief: Esperion Therapeutics Enters First Amendment To Credit Agreement On April 2, 2026 - SEC Filing
02/04/2026 22:33
April 2 (Reuters) - Esperion Therapeutics Inc ESPR.O: ESPERION THERAPEUTICS INC - ENTERS FIRST AMENDMENT TO CREDIT AGREEMENT ON APRIL 2, 2026 - SEC FILING ESPERION THERAPEUTICS INC - INCURS $25 MILLION IN ADDITIONAL TERM LOANS ON APRIL 2, 2026 - SEC FILING Source text: [ID:n0001628280-26-023196] Further company coverage: ESPR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Esperion Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi